Literature DB >> 31391933

Long-Term Outcomes of Autoimmune Hepatitis.

Dermot Gleeson1.   

Abstract

Entities:  

Year:  2019        PMID： 31391933      PMCID： PMC6677096          DOI： 10.1002/cld.797

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  22 in total

1.  British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis.

Authors:  Dermot Gleeson; Michael A Heneghan
Journal:  Gut       Date:  2011-07-13       Impact factor: 23.059

Review 2.  Glucocorticoids and cardiovascular disease.

Authors:  Brian R Walker
Journal:  Eur J Endocrinol       Date:  2007-11       Impact factor: 6.664

3.  Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission.

Authors:  Nicole M F van Gerven; Bart J Verwer; Birgit I Witte; Bart van Hoek; Minneke J Coenraad; Karel J van Erpecum; Ulrich Beuers; Henk R van Buuren; Rob A de Man; Joost P H Drenth; Jannie W den Ouden; Robert C Verdonk; Ger H Koek; Johannes T Brouwer; Maureen M J Guichelaar; Chris J J Mulder; Karin M J van Nieuwkerk; Gerd Bouma
Journal:  J Hepatol       Date:  2012-09-16       Impact factor: 25.083

4.  Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience.

Authors:  S Kanzler; H Löhr; G Gerken; P R Galle; A W Lohse
Journal:  Z Gastroenterol       Date:  2001-05       Impact factor: 2.000

5.  Long-term outcome of Japanese patients with type 1 autoimmune hepatitis.

Authors:  Kaname Yoshizawa; Akihiro Matsumoto; Tetsuya Ichijo; Takeji Umemura; Satoru Joshita; Michiharu Komatsu; Naoki Tanaka; Eiji Tanaka; Masao Ota; Yoshihiko Katsuyama; Kendo Kiyosawa; Masanori Abe; Morikazu Onji
Journal:  Hepatology       Date:  2012-07-06       Impact factor: 17.425

6.  Long-term outcomes of patients with autoimmune hepatitis managed at a nontransplant center.

Authors:  Barbara Hoeroldt; Elaine McFarlane; Asha Dube; Pandurangan Basumani; Mohammed Karajeh; Michael J Campbell; Dermot Gleeson
Journal:  Gastroenterology       Date:  2011-03-09       Impact factor: 22.682

7.  Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment response.

Authors:  Mårten Werner; Sven Wallerstedt; Stefan Lindgren; Sven Almer; Einar Björnsson; Annika Bergquist; Hanne Prytz; Hanna Sandberg-Gertzén; Rolf Hultcrantz; Per Sangfelt; Ola Weiland; Bodil Ohlsson; Ake Danielsson
Journal:  Scand J Gastroenterol       Date:  2010-04       Impact factor: 2.423

8.  Predictors of poor outcome in patients w ith autoimmune hepatitis: a population-based study.

Authors:  Jing Hieng Ngu; Richard Blair Gearry; Chris Miles Frampton; Catherine A M Stedman
Journal:  Hepatology       Date:  2013-05-01       Impact factor: 17.425

9.  Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis.

Authors:  Thawab Al-Chalabi; James A Underhill; Bernard C Portmann; Ian G McFarlane; Michael A Heneghan
Journal:  J Hepatol       Date:  2007-10-22       Impact factor: 25.083

10.  Clinical features and long term outcome of 102 treated autoimmune hepatitis patients.

Authors:  Zinab Malekzadeh; Sepideh Haghazali; Sadaf G Sepanlou; Homayoon Vahedi; Shahin Merat; Masoud Sotoudeh; Siavosh Nasseri-Moghaddam; Reza Malekzadeh
Journal:  Hepat Mon       Date:  2012-02-29       Impact factor: 0.660
View more
  3 in total

1.  Differential IgG4-Producing Plasma Cell Infiltration in Non- and Post-Transplant Plasma Cell Hepatitis.

Authors:  Brian H Horwich; Tom Z Liang; Jennifer L Dodge; Shefali Chopra; Jeffrey A Kahn; Takeshi Saito
Journal:  Transpl Int       Date:  2022-03-18       Impact factor: 3.842

2.  Intrahepatic activated leukocyte cell adhesion molecule induces CD6highCD4+ T cell infiltration in autoimmune hepatitis.

Authors:  Qiwei Qian; Nana Cui; Bingyuan Huang; Yudong Zhao; Qiaoyan Liu; Mingli Hu; Bo Li; Qixia Wang; Qi Miao; Zhengrui You; Xiong Ma; Ruqi Tang
Journal:  Front Immunol       Date:  2022-09-09       Impact factor: 8.786

Review 3.  Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases.

Authors:  Naomi Richardson; Sky T H Ng; David C Wraith
Journal:  Front Immunol       Date:  2020-07-21       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.